| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
AIสามารถช่วยในการทำนายการให้รายละเอียดเพื่อความแม่นยำ |
https://www.spectral-ai.com/blog/artificial-intelligence-in-medical-imaging/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Helps in scheduling patient visits |
|
ปัจจุบันมีโรงพยาบาลที่นำradiology AIมาช่วยคัดกรอง วิเคราะห์และวินิจฉัยเหมือนเป็นผู้ช่วยรังสีแพทย์ |
https://www.bumrungrad.com/th/blog-news/radiology-ai-assisting-analyzing-lungs-breast-cancer |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Legal knowledge about AI usage |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
สีของAIไม่น่าเกี่ยวข้องกับการทำงานและระบบต่างๆของAI |
https://www.sciencedirect.com/science/article/pii/S0933365723002129 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Influences AI's diagnostic accuracy |
|
|
https://www.sciencedirect.com/science/article/pii/S0736585322001587 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
คนกังวลถึงเรื่องความปลอดภัย และยังไม่เชื่อใจAI |
การใช้AIเข้ามาช่วยในระบบการแพทย์ถือเป็นเรื่องดีในด้านการก้าวหน้าทางเทคโนโนยี แต่การรักษายังควรอยู่ในดุลพินิจของแพทย์ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
AIต้องมีความเข้าใจในความเป็นมนุษย์ |
https://pubmed.ncbi.nlm.nih.gov/38184343/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
The age and experience of the healthcare professionals |
|
คนต้องการความมั่นใจในการรักษาร่างกายตนเอง ประสบการณ์และความรู้เป็นสิ่งสำคัญ |
https://pubmed.ncbi.nlm.nih.gov/38184343/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Ensuring fairness and addressing biases is paramount to uphold ethical standards in AI-driven healthcare solutions. Transparency and explainability of AI decision-making processes are essential to maintain trust and accountability, particularly in a field that is sensitive such as healthcare |
https://pmc.ncbi.nlm.nih.gov/articles/PMC11230076/ |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson’s disease เกิดจากการหายไปของdopaminergic neuron |
https://www.medicalnewstoday.com/articles/stem-cell-therapy-for-parkinsons |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
ระบบประสาทของหนูนิยมนำมาทดลองแทนมนุษย์ |
https://www.sciencedirect.com/science/article/pii/S1934590923003211 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
6 months |
|
study was performed to provide supportive safety data for long-term use of intravenous ceftriaxone in a clinical trial in patients with amyotrophic lateral sclerosis |
https://www.sciencedirect.com/science/article/pii/S2214750015300640 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
Cell replacement therapies for Parkinson’s disease (PD) based on transplantation of pluripotent stem cell-derived dopaminergic neurons are now entering clinical trials. Here, we present quality, safety, and efficacy data supporting the first-in-human STEM-PD phase I/IIa clinical trial along with the trial design |
https://www.sciencedirect.com/science/article/pii/S1934590923003211 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
|
https://www.sciencedirect.com/science/article/pii/S1934590923003211 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells increased cognitive impairments. |
|
|
https://www.sciencedirect.com/science/article/pii/S1934590923003211 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
FOXA2 and OTX2 |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|